Recently, Cansino Biotech's ACYW135 group meningococcal polysaccharide conjugate vaccine drug supplement application received a “Notice of Acceptance” issued by the State Drug Administration. This supplementary application expands the age range of people eligible for MANHEXIN® from “children aged 3 months to 3 years” to “children aged 3 months to 6 years”. Manhaixin was approved by the China Drug Administration on December 29, 2021.

Recently, Cansino Biotech's ACYW135 group meningococcal polysaccharide conjugate vaccine drug supplement application received a “Notice of Acceptance” issued by the State Drug Administration. This supplementary application expands the age range of people eligible for MANHEXIN® from “children aged 3 months to 3 years” to “children aged 3 months to 6 years”. Manhaixin was approved by the China Drug Administration on December 29, 2021.